Document is current
Any future updates will be listed below
-
Authors
Shellvarajah, Mekala
Nguyen, Vuong
Steinmann, Sarah
Gillies, Mark C.
Sagkriotis, Alexandros
Barthelmes, Daniel
-
Funding
Funding for this research was provided by:
Novartis
- License Information
-
More Information
Article History
Received: 19 February 2025
Accepted: 31 March 2025
First Online: 15 April 2025
Declarations
:
: Daniel Barthelmes has received research grants from Novartis and Bayer and is a consultant for Alcon and Bayer. Mark Gillies is a consultant for, and has received travel support, honoraria, and research support from Bayer and Novartis. Alexandros Sagkriotis is a Novartis employee and shareholder. Mekala Shellvarajah, Vuong Nguyen, and Sarah Steinmann have nothing to disclose. None of the authors have any proprietary interests.
: All patients included in the study provided their consent to be included in the registry and for their data to be published in anonymized form. Ethical approval for the study was obtained from the Cantonal Ethics Committee, Zurich. This study was conducted in accordance with the Declaration of Helsinki (1964) and its later amendments.
